Subsequently, they found that IL-4 treatment and IL-4/ interleukin 10 (IL-10) co-treatment was able to significantly reduce blood pressure and prevent endothelial dysfunction in a TLR3-induced PE mouse model [139]. Here, IL4 is linked to endothelial dysfunction.